Highlights Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Market Closed - NSE India S.E. Other stock markets 07:43:55 2024-07-12 am EDT			5-day change	1st Jan Change
658.6 ^INR	-1.43%		-0.24%	+99.39%

Jul. 10	Shilpa Medicare Arm's API Facility in Karnataka, India, Passes Brazilian Drug Regulator's Inspection	MT
Jul. 09	Shilpa Medicare to Receive Shares from Unit as Loan Payment	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Shilpa Medicare Arm's API Facility in Karnataka, India, Passes Brazilian Drug Regulator's Inspection	Jul. 10	MT
Shilpa Medicare to Receive Shares from Unit as Loan Payment	Jul. 09	MT
Shilpa Medicare Shares Rally 16% as Client Reports Positive Clinical Trial Results	Jul. 05	MT
INDIA STOCKS-HDFC Bank drags Indian shares as rally to record highs takes pause	Jul. 05	RE
Unicycive Therapeutics, Inc. Enters into First Amendment to Manufacturing and Supply Agreement with Shilpa Medicare, Ltd	Jul. 02	CI
Shilpa Medicare Bio Analytical Unit Gets "No Action Indicated" Classification from US FDA	Jun. 25	MT
Shilpa Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 23	CI
Shilpa Medicare Limited Announces Successful Completion of Early Clinical Development and Ongoing Phase 3 Clinical Trial of Its Newly Developed Drug "SML-007", for the Treatment of Non-Alalcoholic Fatty Liver Disease	May. 14	CI
Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	Apr. 18	MT
Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	Apr. 17	MT
Shilpa Medicare Gets Board Nod to Launch QIP	Apr. 09	MT
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA	Mar. 01	MT
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe	Feb. 26	MT
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug	Jan. 19	MT
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Shilpa Medicare Acquires US-Based Pilnova Pharma	Nov. 02	MT
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal	23-10-11	CI
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection	23-09-04	MT
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms	23-09-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shilpa Medicare Limited NSE India S.E.

Equities

SHILPAMED

INE790G01031

Highlights

Filters